| Literature DB >> 31080783 |
Qing Quan1,2, Qi Zheng1,3, Yinghui Ling1,3, Fugui Fang1,3, Mingxing Chu4, Xiaorong Zhang1,3, Yong Liu5, Wenyong Li5.
Abstract
BACKGROUND: A multitude of genes tightly regulate ovarian follicular development and hormone secretion. These complex and coordinated biological processes are altered during pregnancy. In order to further understand the regulatory role of these genes during pregnancy, it is important to screen the differentially expressed genes (DEGs) in the ovaries of pregnant and nonpregnant mammals. To detect the genes associated with the development of pregnancy in goats, DEGs from the ovaries from pregnant and nonpregnant Anhui white goats (pAWGs and nAWGs, respectively) were analyzed using RNA sequencing technology (RNA-Seq).Entities:
Keywords: Differentially expressed genes; Goat; Ovary; Pregnant and nonpregnant; RNA-Seq
Year: 2019 PMID: 31080783 PMCID: PMC6503366 DOI: 10.1186/s40709-019-0095-9
Source DB: PubMed Journal: J Biol Res (Thessalon) ISSN: 1790-045X Impact factor: 1.889
The primers used for real-time quantitative PCR analysis
| Gene name | Primer sequence |
|---|---|
|
| S: 5′-ATCCCCGACTCCGTCAGTTT-3′ |
|
| S: 5′-AAATGAATGGCGTCGTCCTAG-3′ |
|
| S: 5′-GGCTCGCCCTATGTAAGAATG-3′ |
|
| S: 5′-AAGCAACTATGTGGCAGAGCAG-3′ |
|
| S: 5′-TGCCCAACTCACAACAGAACAT-3′ |
|
| S: 5′-CCCTATGAAGCCTGTGATGGT-3′ |
|
| S: 5′-CTTGCATTGACTGTGCTGCTC-3′ |
|
| S: 5′-TCCGCAAAGACCCTGACATC-3′ |
|
| S: 5′-GCATCGTGGAGGGACTTATGAC-3′ |
Fig. 1Summary of genetic analysis procedures for pregnant and unpregnant goats
Details of the differentially expressed genes (DEGs) associated with reproduction
| Gene ID | Description | log2 ratio (pregnant ovary/non-pregnant ovary) | |
|---|---|---|---|
| gi|548512269|ref|XM_005694809.1 | gi|339460411|gb|AEJ76924.1|/0/prolactin receptor long form | 9.971617 | 1.46E−4 |
| gi|548524371|ref|XM_005698829.1 | gi|57163979|ref|NP_001009243.1|/5.24994e-157/steroidogenic acute regulatory protein, mitochondrial precursor | 6.621061 | 4.65E−345 |
| gi|548458406|ref|XM_005677785.1 | gi|440906469|gb|ELR56725.1|/0/3 beta-hydroxysteroid dehydrogenase/Delta 5–>4-isomerase, partial | 5.578285 | 3.93E−398 |
| gi|548485096|ref|XM_005686390.1 | gi|426223863|ref|XP_004006093.1|/1.84864e-105/PREDICTED:3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 4.690717 | 8.63E−14 |
| gi|548470003|ref|XM_005681450.1 | gi|162946588|gb|ABY21280.1|/4.77201e-131/osteopontin | 4.535885 | 1.66E−367 |
| gi|548485794|ref|XM_005686598.1 | gi|426226402|ref|XP_004007333.1|/0/PREDICTED:lutropin-choriogonadotropic hormone receptor | 3.872696 | 8.91E−327 |
| gi|548469920|ref|XM_005681410.1 | gi|193876570|gb|ACF24869.1|/0/bone morphogenetic protein 1B | 3.614874 | 9.33E−19 |
| gi|548503561|ref|XM_005692140.1 | gi|1911705|gb|AAB50810.1|/0/11 beta-hydroxysteroid dehydrogenase type 2 | 3.415309 | 1.40E−40 |
| gi|548500629|ref|XM_005691343.1 | gi|426247178|ref|XP_004017363.1|/0/PREDICTED: scavenger receptor class B member 1 | 3.208502 | 1.10E−288 |
| gi|548472488|ref|XM_005682375.1 | gi|426228997|ref|XP_004008580.1|/0/PREDICTED: low-density lipoprotein receptor | 1.829713 | 2.89E−384 |
| gi|548476777|ref|XM_005683765.1 | gi|426222344|ref|XP_004005354.1|/0/PREDICTED: very low-density lipoprotein receptor | 1.749974 | 1.38E−44 |
| gi|548456104|ref|XM_005677120. | gi|426217043|ref|XP_004002763.1|/0/PREDICTED: 3-keto-steroid reductase | 1.467141 | 4.31E−19 |
| gi|548518653|ref|XM_005696914.1 | gi|296473962|tpg|DAA16077.1|/1.29128e-162/TPA: bone morphogenetic protein 6-like | 1.434549 | 3.27E−30 |
| gi|548517737|ref|XM_005696509.1 | gi|254892264|dbj|BAH86639.1|/2.61573e-94/vascular endothelial growth factor 188 | 1.225192 | 2.47E−70 |
| gi|548496483|ref|XM_005690127.1 | gi|426245339|ref|XP_004016470.1|/4.26298e-173/PREDICTED:estradiol 17-beta-dehydrogenase 12 | 1.071481 | 8.17E−25 |
| gi|548454974|ref|XM_005676599.1 | gi|347990733|gb|AEP40507.1|/1.39972e-120/INHA | − 5.33697 | 1.21E−322 |
| gi|548463672|ref|XM_005679345.1 | gi|338807808|gb|AEJ07667.1|/0/inhibin beta A subunit | − 4.78646 | 2.89E−311 |
| gi|548483458|ref|XM_005685776.1 | gi|172088165|ref|NP_001116472.1|/0/cytochrome P450 19A1 | − 3.42394 | 6.98E−348 |
| gi|548454408|ref|XM_005676322.1 | gi|440900738|gb|ELR51808.1|/1.70145e-143/Inhibin beta B chain, partial | − 2.67258 | 7.97E−227 |
| gi|548510550|ref|XM_005694322.1 | gi|440903234|gb|ELR53921.1|/1.18142e-66/Estradiol 17-beta-dehydrogenase 1 | − 2.52176 | 2.49E−96 |
| gi|548485697|ref|XM_005686583.1 | gi|193876578|gb|ACF24872.1|/0/follicle stimulating hormone receptor | − 2.22307 | 1.24E−12 |
| gi|548483859|ref|XM_005685967.1 | gi|193876584|gb|ACF24875.1|/0/estrogen receptor beta | − 1.62217 | 6.99E−11 |
| gi|548494087|ref|XM_005689375.1 | gi|426245562|ref|XP_004016579.1|/0/PREDICTED:progesterone receptor | − 1.27381 | 7.88E−15 |
Fig. 2Comparison of RNA-Seq (Quantification) and qPCR results. Results represent the mean (± SD) of three experiments. *p ≤ 0.05
Fig. 3Histogram of the Gene Ontology (GO) classifications. The results are summarized for the following three main categories: “biological process”, “cellular component”, and “molecular function”. Among these groups, the GO terms “cellular process”, “binding”, “cell”, and “cell part” predominated in each of the three main categories. The reproduction-related GO terms were underlined
Fig. 4Top 20 pathway enrichment assignments for nonpregnant and pregnant ovaries. The Q value is the corrected p value ranging from 0 to 1. The lower the Q value, the greater the intensity. Red lines are significantly enriched signal pathways
Fig. 5“Cytokine–cytokine receptor interaction”, “steroid biosynthesis” and “cell cycle” pathway and the identified regulator
The significantly enriched pathways among the DEGs between the pregnant and nonpregnant
| Pathway | DEGs with pathway annotation (1413) | All genes with pathway annotation (22,885) | Q value | Pathway ID | |
|---|---|---|---|---|---|
| Complement and coagulation cascades | 51 (3.61%) | 235 (1.03%) | 2.05E−15 | 4.95E−13 | ko04610 |
| 33 (2.34%) | 181 (0.79%) | 1.88E−08 | 2.28E−06 | ko05150 | |
| Hematopoietic cell lineage | 30 (2.12%) | 212 (0.93%) | 1.87E−05 | 1.21E−03 | ko04640 |
| Bile secretion | 28 (1.98%) | 192 (0.84%) | 2.00E−05 | 1.21E−03 | ko04976 |
| Cytokine–cytokine receptor interaction | 46 (3.26%) | 395 (1.73%) | 2.70E−05 | 1.31E−03 | ko04060 |
| DNA replication | 12 (0.85%) | 51 (0.22%) | 4.89E−05 | 1.97E−03 | ko03030 |
| Systemic lupus erythematosus | 31 (2.19%) | 241 (1.05%) | 8.77E−05 | 3.03E−03 | ko05322 |
| Axon guidance | 44 (3.11%) | 403 (1.76%) | 0.000178193 | 5.39E−03 | ko04360 |
| Pertussis | 23 (1.63%) | 177 (0.77%) | 0.000587109 | 1.58E−02 | ko05133 |
| Cell cycle | 31 (2.19%) | 273 (1.19%) | 0.000795974 | 1.93E−02 | ko04110 |
| Vitamin digestion and absorption | 13 (0.92%) | 78 (0.34%) | 0.000920767 | 2.03E−02 | ko04977 |
| Steroid biosynthesis | 10 (0.71%) | 54 (0.24%) | 0.001541861 | 3.11E−02 | ko00100 |